Screening Protocol for Adults With ADHD
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00592254 |
Recruitment Status : Unknown
Verified January 2022 by Joseph Biederman, MD, Massachusetts General Hospital.
Recruitment status was: Active, not recruiting
First Posted : January 14, 2008
Last Update Posted : January 18, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
ADHD |
Study Type : | Observational |
Estimated Enrollment : | 3000 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Official Title: | A Screening Protocol for Adults With Attention Deficit Hyperactivity Disorder |
Study Start Date : | December 2002 |
Estimated Primary Completion Date : | December 2023 |
Estimated Study Completion Date : | December 2023 |
Group/Cohort |
---|
A |
- Screening Protocol [ Time Frame: Sreening ]This study is a prescreening for possible entry into other studies
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 55 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Males and females ages 18-55
- Subjects must have a DSM-IV or DSM-V diagnosis of ADHD, as determined by a clinical evaluation based on DSM-IV or DSM-V criteria
Exclusion Criteria:
- History of head trauma with loss of consciousness, organic brain disorders, seizures, or neurosurgical intervention.
- Any significant medical condition, in the judgment of the investigator
- Mental retardation
- Pregnancy of lactation
- Subjects with a known recent history (within the past 6 months) of illicit drug or alcohol dependence
- Sensory difficulties such as deafness or blindness
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00592254
United States, Massachusetts | |
Massachusetts General Hospital | |
Boston, Massachusetts, United States, 02114 |
Principal Investigator: | Joseph Biederman, MD | Massachusetts General Hospital |
Responsible Party: | Joseph Biederman, MD, Chief, Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital |
ClinicalTrials.gov Identifier: | NCT00592254 |
Other Study ID Numbers: |
2002-P-001856 |
First Posted: | January 14, 2008 Key Record Dates |
Last Update Posted: | January 18, 2022 |
Last Verified: | January 2022 |
ADHD Adults |